Ninety One (UK)’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History
Bought
Maintained
Sold
Other funds holding WX
Ninety One (UK)'s WX Position: Q1 2016 in Review
Ninety One (UK) sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q1 2016, closing a stake of 1,451 shares — an estimated $67K sold.
Ninety One (UK) first reported a position in WX in Q2 2013 and held it in 11 quarters. The position peaked at $112M in Q2 2015. 1 fund tracked by Wall St. Rank holds WX as of Q1 2016.
- Ninety One (UK) reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q1 2016 after selling out during the quarter.
- Ninety One (UK) sold 1,451 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q1 2016, an estimated $67K.
- Ninety One (UK) first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 11 quarters.
- Ninety One (UK)'s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $112M in Q2 2015.
- 1 fund tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q1 2016.
Based on Ninety One (UK)'s 13F filing for Q1 2016, filed 12 May 2016.